Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

Por Martinelli, E, De Palma, R, Orditura, M, De Vita, F, Ciardiello, F
Publicado em 2009

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

Por Comella, P, Casaretti, R, Crucitta, E, De Vita, F, Palmeri, S, Avallone, A, Orditura, M, De Lucia, L, Del Prete, S, Catalano, G, Lorusso, V, Comella, G
Publicado em 2002

A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)

Por Aurilio, G, Ricci, V, De Vita, F, Fasano, M, Fazio, N, Orditura, M, Funicelli, L, De Luca, G, Iasevoli, D, Iovino, F, Ciardiello, F, Conzo, G, Nolè, F, Lamendola, MG
Publicado em 2010

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

Por Ciardiello, F, Troiani, T, Caputo, F, De Laurentiis, M, Tortora, G, Palmieri, G, De Vita, F, Diadema, M R, Orditura, M, Colantuoni, G, Gridelli, C, Catalano, G, De Placido, S, Bianco, A R
Publicado em 2006

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer

Por Morgillo, F., De Vita, F., Antoniol, G., Orditura, M., Auriemma, P.P., Diadema, M.R., Lieto, E., Savastano, B., Festino, L., Laterza, M.M., Fabozzi, A., Ventriglia, J., Petrillo, A., Ciardiello, F., Barbarisi, A., Iovino, F.
Publicado em 2013

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

Por De Vita, F, Orditura, M, Matano, E, Bianco, R, Carlomagno, C, Infusino, S, Damiano, V, Simeone, E, Diadema, M R, Lieto, E, Castellano, P, Pepe, S, De Placido, S, Galizia, G, Di Martino, N, Ciardiello, F, Catalano, G, Bianco, A R
Publicado em 2005

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer

Por De Vita, F, Orditura, M, Martinelli, E, Vecchione, L, Innocenti, R, Sileni, V C, Pinto, C, Di Maio, M, Farella, A, Troiani, T, Morgillo, F, Napolitano, V, Ancona, E, Di Martino, N, Ruol, A, Galizia, G, Del Genio, A, Ciardiello, F
Publicado em 2011

Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study

Por Orditura, M., Galizia, G., Di Martino, N., Ancona, E., Castoro, C., Pacelli, R., Morgillo, F., Rossetti, S., Gambardella, V., Farella, A., Laterza, M.M., Ruol, A., Fabozzi, A., Napolitano, V., Iovino, F., Lieto, E., Fei, L., Conzo, G., Ciardiello, F., De Vita, F.
Publicado em 2014

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial

Por Martinelli, E, Cardone, C, Troiani, T, Normanno, N, Pisconti, S, Sforza, V, Bordonaro, A R, Rachiglio, A M, Lambiase, M, Latiano, T P, Modoni, G, Cordio, S, Giuliani, F, Biglietto, M, Montesarchio, V, Barone, C, Tonini, G, Cinieri, S, Febbraro, A, Rizzi, D, De Vita, F, Orditura, M, Colucci, G, Maiello, E, Ciardiello, F
Publicado no ESMO Open (2017)